Filter Results
:
(5,251)
Show Results For
-
All HBS Web
(5,251)
- People (23)
- News (1,238)
- Research (2,555)
- Events (33)
- Multimedia (53)
- Faculty Publications (1,724)
Show Results For
-
All HBS Web
(5,251)
- People (23)
- News (1,238)
- Research (2,555)
- Events (33)
- Multimedia (53)
- Faculty Publications (1,724)
- 01 Jan 2014
- News
IDEO’s Culture of Helping
- September 2017
- Case
Dr. William Carson— Intrapreneurial Innovation in the Pharmaceutical Industry
By: Steven Rogers and Alyssa Haywoode
Dr. William Carson, an African-American alum of Harvard University became the President and CEO of a multi billion dollar division of Otsuka, a Japan based pharmaceutical company. His ascension to this leadership position followed a thriving career in academic medicine...
View Details
Keywords:
Dr. Williams Carson;
Otsuka America Pharmaceutical;
Harvard;
Abilify;
Aripiprazole;
Health Testing and Trials;
Globalized Firms and Management;
Globalized Markets and Industries;
Cross-Cultural and Cross-Border Issues;
Decision Choices and Conditions;
Pharmaceutical Industry;
Japan
Rogers, Steven, and Alyssa Haywoode. "Dr. William Carson— Intrapreneurial Innovation in the Pharmaceutical Industry." Harvard Business School Case 318-005, September 2017.
- April 2006
- Background Note
Managing Innovation in an Uncertain World: Module 1: Innovation and Uncertainty
Describes the first module of a Harvard Business School 30-session elective course called Managing Innovation in an Uncertain World. The course helps students understand the challenges that uncertainty implies for innovation and how to overcome these challenges. The...
View Details
Keywords:
Design;
Curriculum and Courses;
Innovation and Management;
Projects;
Opportunities;
Perspective
MacCormack, Alan D. "Managing Innovation in an Uncertain World: Module 1: Innovation and Uncertainty." Harvard Business School Background Note 606-125, April 2006.
- September 1983 (Revised October 1984)
- Case
Syntex Laboratories (A)
A consulting project involving a mathematical model of the sales force indicates that Syntex Labs should nearly double the size of their sales force and drastically alter their allocation of sales effort to the product line and physician specialties. The questions are...
View Details
Keywords:
Organizational Change and Adaptation;
Strategic Planning;
Salesforce Management;
Pharmaceutical Industry
Clarke, Darral G. "Syntex Laboratories (A)." Harvard Business School Case 584-033, September 1983. (Revised October 1984.)
- Career Coach
Roshan Tathed
Roshan wants to help students think critically about their career paths and what really matters most to them. Having worked extensively across Healthcare, Telecom, Media, Technology, Fintech and Edutech across big tech, startups, and top management consulting firms,...
View Details
- 27 Sep 2015
- News
Pharma gives drug development the Hollywood treatment
- 16 Apr 2013
- News
New Guidelines to Help Companies Report on Sustainability Issues
- Web
Online Business Analytics Course | HBS Online
has helped me pursue a career in data analytics and land a job as a Business Intelligence Analyst at Ministry of Justice New Zealand. I'm leading a few modelling and reporting projects across the Ministry using the knowledge I gained from...
View Details
James I. Cash
Professor Cash received a Bachelor of Science degree in Mathematics from Texas Christian University; a Master of Science in Computer Science from Purdue University's Graduate School of Mathematical Sciences; and a Doctor of Philosophy in Management Information... View Details
William C. Kirby
William C. Kirby is T. M. Chang Professor of China Studies at Harvard University and Spangler Family Professor of Business Administration at the Harvard Business School. He is a Harvard University Distinguished Service Professor. He serves as Chairman of the Harvard... View Details
- October 22, 2015
- Article
The Mayo Clinic Model for Running a Value-Improvement Program
By: Robert S. Kaplan, Derek A. Haas, Richard A. Helmers, March Rucci and Meredith Brady
Applying time-driven activity-based costing (TDABC) in health care cannot be delegated to the finance function. The most successful implementations have had strong executive support, exceptional clinical leaders, and dedicated, multi-disciplinary project teams. The...
View Details
Keywords:
Service Delivery;
Activity Based Costing and Management;
Health Care and Treatment;
Health Industry
Kaplan, Robert S., Derek A. Haas, Richard A. Helmers, March Rucci, and Meredith Brady. "The Mayo Clinic Model for Running a Value-Improvement Program." Harvard Business Review (website) (October 22, 2015). (A collaboration of the editors of Harvard Business Review and the New England Journal of Medicine.)
- November 2003 (Revised March 2004)
- Case
Federal Express: Early History
Describes key events in the start-up of Federal Express. Outlines the company's value proposition and provides an overview of key competitors in the air freight industry. This case is used with Teledesic (Abridged), HBS No. 9-804-096, which describes a failed project...
View Details
Lovelock, Christopher H. "Federal Express: Early History." Harvard Business School Case 804-095, November 2003. (Revised March 2004.)
- October 1996
- Case
Jim Bender and Alert, Inc. (A)
Jim Bender has just been hired as CEO of Alert, Inc. Alert, founded in 1986 by a charismatic technologist, has accumulated an impressive portfolio of patents and leading edge technology projects in a variety of fields. The company has never, however, shown a profit and...
View Details
Keywords:
Business or Company Management;
Entrepreneurship;
Management Skills;
Business Startups;
Technology Industry
Bhide, Amar, and Robert W. Lightfoot. "Jim Bender and Alert, Inc. (A)." Harvard Business School Case 897-009, October 1996.
- February 1986 (Revised March 1990)
- Supplement
Copeland Corp.: Evolution of a Manufacturing Strategy--1975-82 (C)
By: David A. Garvin
In the preceding case, Copeland had to choose between two alternative plant layouts for organizing its Sidney plant. Now it must get work force approval for a change in "bumping" rules before proceeding with the change. Management must decide how to proceed--to...
View Details
Keywords:
Strategy;
Production;
Factories, Labs, and Plants;
Labor and Management Relations;
Restructuring;
Decisions;
Change Management;
Manufacturing Industry;
Ohio
Garvin, David A. "Copeland Corp.: Evolution of a Manufacturing Strategy--1975-82 (C)." Harvard Business School Supplement 686-090, February 1986. (Revised March 1990.)
- 06 Jun 2011
- News
IBM and Six Strategic Reasons to Celebrate by Serving
- 23 Feb 2022
- News
More-Experienced Entrepreneurs Have Bigger Deadline Problems
- 26 Jun 2021
- News
Activision Shows the Case for Changing the CEO Pay Game
- 24 Jun 2016
- News
What Brexit Means for the Openness of the World Economy
- 13 Jan 2011
- News
Early ecocities
- Article
Wisdom or Madness? Comparing Crowds with Expert Evaluation in Funding the Arts
By: Ethan Mollick and Ramana Nanda
In fields as diverse as technology entrepreneurship and the arts, crowds of interested stakeholders are increasingly responsible for deciding which innovations to fund, a privilege that was previously reserved for a few experts, such as venture capitalists and...
View Details
Keywords:
Crowdfunding;
Arts;
Decision Choices and Conditions;
Entrepreneurship;
Investment;
Fine Arts Industry;
Technology Industry
Mollick, Ethan, and Ramana Nanda. "Wisdom or Madness? Comparing Crowds with Expert Evaluation in Funding the Arts." Management Science 62, no. 6 (June 2016): 1533–1553.